how many glp-1 agonists are there Market Exclusive Research Report 2025 Evolution of GLP‐1 Receptor Agonists

Provenance and peer review: Unsolicited article

Breast adenocarcinoma Prostate adenocarcinoma Non-small cell lung cancer (NSCLC) Colorectal adenocarcinoma Hepatocellular carcinoma (liver cancer) Renal cell carcinoma Pancreatic adenocarcinoma Half of the participants started a GLP-1 medication semaglutide, tirzepatide, dulaglutide, liraglutide, lixisenatide or pramlintide after their cancer diagnosis

5 They established the insulinotropic actions of GLP-1 in humans and found that they were more effective than the glucose-dependent insulinotropic polypeptide (GIP) in stimulating insulin and reducing peak plasma glucose concentrations

PubMed: Tirzepatide trials

Because GLP-1 agonists delay gastric emptying, there have been reports of patients aspirating (inhaling) gastric contents during anesthesia, even after standard fasting protocols

Moreover, small reductions in body weight alone can have beneficial effects on blood pressure as well as glucose and cholesterol metabolism (Klein et al., 2004